Clinical Trials Logo

Filter by:
NCT ID: NCT02763904 Recruiting - Nutritional Support Clinical Trials

Systematic Oral Nutritional Support in Hospitalized, Moderately Hypophagic Patients at Nutritional Risk

Start date: July 2016
Phase: N/A
Study type: Interventional

Protein-calorie malnutrition is a frequent comorbidity in hospitalized patients and there is evidence that the nutritional status may influence the response to drug treatment, mortality, susceptibility to infections, the patient's functional status, duration of hospital stay and, consequently, overall healthcare costs. The causes of malnutrition are manifold. The underlying disease may in fact lead to an increase in the patient's energy needs, whether or not associated with a reduction in caloric intake. The same therapeutic treatments can further worsen the energy balance without considering that the patient can be kept fasting for the execution of some diagnostic procedures. Therefore, a further deterioration of nutritional status during hospitalization could occur. International guidelines underline the utility to set a nutritional support whenever this is necessary, not only to prevent or treat malnutrition but also improve clinical outcomes. In this perspective, the improvement of oral diet and the use of oral nutritional supplements (ONS) represent the first-line strategy of intervention. Previous studies have shown that nutritional counseling, with or without the use of ONS, in patients with chronic disease is able to improve the calorie-protein intake, prevent deterioration of nutritional status, as well as to increase to a certain extent body weight. Particularly, energy-dense are more effective in increase energy intake. These data have highlighted the importance of a proper evaluation of the nutritional status of early detection of patients who could benefit of nutritional support. However, the independent role of the ONS in improving clinical outcome still needs to be established.

NCT ID: NCT02762344 Recruiting - Clinical trials for Embolism and Thrombosis of the Radial Artery

Radial Artery Occlusion After Endovascular Procedure

Start date: May 2016
Phase: N/A
Study type: Observational [Patient Registry]

Observational cohort registry: prospective, multicenter independent evaluation of patients who undergo coronary angiography and/or PCI via radial artery. The purpose of this registry is to set the incidence of RAO according to ACT values, considered both as continuous and ordinal variable and its determinants. Coronary angiography and PCI will be performed according to usual practice.

NCT ID: NCT02762214 Recruiting - Endometrial Cancer Clinical Trials

Role of Uterine Manipulator in Hysterectomy - Ro.Man.HY

RoManHy
Start date: October 2015
Phase: Phase 3
Study type: Interventional

Prospective multicentric randomized trial to evaluate the role of uterine manipulator on laparoscopic/robotic total hysterectomy for the treatment of early stage G1 - G2 endometrial cancer (International Federation of Gynecology and Obstetrics - FIGO stages IA-IB).

NCT ID: NCT02759419 Recruiting - Clinical trials for Hypertension, Pulmonary

A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.

RIALTO
Start date: June 16, 2016
Phase: Phase 4
Study type: Interventional

To provide riociguat therapy to eligible patients with PAH originating from Bayer-sponsored trials with BAY63-2521/ Riociguat / Adempas® who are currently or recently treated in these trials until lack of patient benefit as assessed by investigator, or commercial availability and reimbursement.

NCT ID: NCT02756468 Recruiting - Pancreatic Cancer Clinical Trials

Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS Study

PREDIPS
Start date: January 2015
Phase: N/A
Study type: Observational [Patient Registry]

Background. Pancreatic cancer surgery is associated with very high risk of postoperative morbidity and mortality. Anastomotic leak (AL) is one of the worst complications associated with relevant short and long-term sequelae. Procalcitonin (PCT) is a biomarker used to monitor bacterial infections and guide antibiotic therapy and has been shown to have better predictive value of AL after colorectal surgery than C-reactive protein (CRP) and white blood cell count (WBC). Purpose. The investigators designed a monocentric pilot study to test if PCT might be a sensitive and reliable marker of AL after pancreatic surgery

NCT ID: NCT02756455 Recruiting - Gastric Cancer Clinical Trials

Procalcitonin Reveals Early Dehiscence in Gastric Surgery: the PREDIGS Study

Start date: January 2015
Phase: N/A
Study type: Observational [Patient Registry]

Background. Gastric cancer surgery is associated with high risk for postoperative morbidity and mortality. Anastomotic leak (AL) is one of the worst complications associated with relevant short and long-term sequelae. Procalcitonin (PCT) is a biomarker used to monitor bacterial infections and guide antibiotic therapy and has been shown to have better predictive value of AL after colorectal surgery than C-reactive protein (CRP) and white blood cell count (WBC). Purpose. Investigators designed a monocentric pilot study to test if PCT might be a sensitive and reliable marker of AL after gastric surgery

NCT ID: NCT02752984 Recruiting - Venous Thrombosis Clinical Trials

Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion

DVT-PICC
Start date: April 2016
Phase: N/A
Study type: Observational

Deep Vein Thrombosis (DVT) is one of the most important complications after Peripherally Inserted Central Catheter (PICC) insertion. This study goals are to understand when and why DVT develops.

NCT ID: NCT02751086 Recruiting - Gastric Cancer Clinical Trials

Robotic, Laparoscopic and Open Gastrectomy Compared on Short and Long Term Outcomes

IMIGASTRICII
Start date: April 2016
Phase:
Study type: Observational

The overall purpose is to develop and maintain a multi-institutional database comprising of information regarding surgical, clinical and oncological features of patients that will be treated for gastric cancer with robotic, laparoscopic or open approaches and subsequent follow-up. The main objective is to compare the three surgical arms on surgical and clinical outcomes, as well as on the oncological follow-up.

NCT ID: NCT02748603 Recruiting - Unstable Angina Clinical Trials

Appropriateness of Coronary Angioplasty in PAtients With isCHEmic Heart Disease

APACHE
Start date: October 2014
Phase: N/A
Study type: Observational

An observational, retrospective, multicenter, blinded adjudication study to evaluate the clinical appropriateness of Percutaneous Coronary Intervention (PCI) indication and execution in patients with stable Coronary Artery Disease (CAD) and in patients with acute coronary syndrome without ST-segment elevation (NSTE-ACS) (ratio 4:1). Half of the included patients will be diabetic. Also the implementation of selected, key guideline recommendations will be examined. At least 400 patients will be retrospectively selected among 22 Catheterization Laboratories in Italy in the region of Lombardia and Veneto. This study will be conducted in compliance with Good Clinical Practices (GCP) including the Declaration of Helsinki and all applicable regulatory requirements.

NCT ID: NCT02748447 Recruiting - Premature Infants Clinical Trials

Automated Adjustment of Inspired Oxygen to Maintaining Regional Cerebral Oxygenation in Preterm Infants on Respiratory Support

Start date: April 2016
Phase: N/A
Study type: Interventional

Background: fluctuation of cerebral blood flow and oxygenation in neonates who undergo intensive care is an important risk factor for risk of neurodevelopmental impairment. Near infrared spectroscopy (NIRS) allow direct measurements of cerebral tissue oxygenation. Automated Fraction of Inspired Oxygen (FiO2) adjustment can maintain arterial oxygen saturation (SpO2) within a target range and may reduce risk of fluctuation of cerebral oxygenation. Aim of this study: to evaluate the efficacy of automated FiO2 adjustment in maintaining SpO2 within a target range and in reducing the risk of cerebral tissue hypo-oxygenation due to SpO2 fluctuations in preterm infants on invasive or non invasive respiratory support with supplemental oxygen.